Reliability and Validity of the Chinese Version of SF-12v2 among the Elderly with Community Home-based Care

doi:10.12114/j.issn.1007-9572.2018.34.020

Abstract

Abstract: Objective　To evaluate the reliability and validity of the second Chinese version of Short-Form 12 Item Health Survey（SF-12v2） in elderly people with community home-based care. Methods　By use of two-stage sampling，a total of 451 older adults with community home-based care were recruited from Guangzhou from July to November 2017. They were surveyed with the Chinese version of SF-12v2. The criterion validity the Chinese version of SF-12v2 was determined by comparison with the ordinal response data of the Chinese version of the Euroqol Group's 5-Domain 5-Level Questionnaire（EQ-5D-5L）. Cronbach's α and Spearman-Brown prophecy formula were used to measure the reliability of the Chinese version of SF-12v2. The validity analysis of the Chinese version of SF-12v2 consisted of content validity（convergent validity and divergent validity），construct validity and criterion validity. Results　The Cronbach's α and split-half reliability with Spearman-Brown adjustment of the Chinese version of SF-12v2 were 0.876，0.873，respectively. The convergent validity and divergent validity for the 8 domains of the Chinese version of SF-12v2 were all 100.0%. Two factors were extracted，explaining 65.94% of the total variance. The scores of physical functioning domain of the Chinese version of SF-12v2 showed a medium correlation with the scores of 4 domains of the Chinese version of EQ-5D-5L，mobility，self-care，usual activities，and pain/discomfort（r=0.591，0.436，0.606，0.590； P<0.01） . The scores of mental health domain of the Chinese version of SF-12v2 had a medium correlation with the scores of the domain of anxiety/depression of the Chinese version of EQ-5D-5L（r=0.517，P<0.01） . Conclusion　The Chinese version of SF-12v2 has good reliability and validity in objectively assessing the health status of older adults with community home-based care.

Key words: Health status, Quality of life, Aged, SF-12v2, Community home-based care, Reliability, Validity

摘要： 目的　探讨应用健康调查12条简表第2版（SF-12v2量表）评价社区居家养老模式下老年人健康状况的信度和效度。方法　2017年7—11月采用两阶段抽样法抽取广州市451名社区居家养老的老年人为研究对象，应用SF-12v2量表对其健康状况进行调查，同时采用欧洲五维健康量表5个维度（EQ-5D-5L）的定序数据作为效标。SF-12v2量表信度分析采用Cronbach's α系数和Spearman-Brown分半信度系数，效度分析采用内容效度（集合效度与区分效度）、结构效度和效标效度。结果　信度方面，SF-12v2量表总的Cronbach's α系数为0.876，两个分半量表的Spearman-Brown分半信度为0.873。效度方面，8个维度的集合效度和区分效度均为100.0%，因子分析提取公因子共2个，累计解释65.94%的总变异，SF-12v2生理健康子量表总分与EQ-5D-5L量表行动能力、自我照顾、日常活动、疼痛/不舒服维度中度相关（r值分别为0.591、0.436、0.606、0.590，P<0.01），SF-12v2心理健康子量表总分与EQ-5D-5L量表焦虑/沮丧维度中度相关（r=0.517，P<0.01）。结论　SF-12v2量表应用于社区居家养老模式下老年人健康状况评价时，具有较好的信度和效度，能够客观反映老年人的健康状况。

关键词: 健康状况, 生活质量, 老年人, SF-12v2量表, 社区居家养老, 信度, 效度

SU Shuwen,WANG Dong. Reliability and Validity of the Chinese Version of SF-12v2 among the Elderly with Community Home-based Care　[J]. Chinese General Practice, 2018, 21(34): 4262-4265. DOI: 10.12114/j.issn.1007-9572.2018.34.020.
苏淑文,王冬. SF-12v2量表评价社区居家养老模式下老年人健康状况的信度和效度分析[J]. 中国全科医学, 2018, 21(34): 4262-4265. DOI: 10.12114/j.issn.1007-9572.2018.34.020.

References

［1］世界卫生组织.关于老龄化与健康的全球报告［R］.日内瓦：世界卫生组织，2015：43-44.
［2］世界卫生组织.中国老龄化与健康国家评估报告［R］.日内瓦：世界卫生组织，2016：1.
［3］穆光宗.家庭空巢化过程中的养老问题［J］.南方人口，2002，17（1）：33-36.
MU G Z.The elderly support issues in empty-nest families［J］.South China Population，2002，17（1）：33-36.
［4］许爱花.中国城市社区老年人养老模式之反思［J］.宁夏大学学报（人文社会科学版），2005，27（3）：108-111.
XU A H.Reflection on the aged care model of urban communities in China ［J］.Journal of Ningxia University（Social Science Edition），2005，27（3）：108-111.
［5］LAM E T，LAM C L，FONG D Y，et al.Is the SF-12 version 2 health survey a valid and equivalent substitute for the SF-36 version 2 health survey for the Chinese?［J］.Journal of Evaluation in Clinical Practice，2013，19（1）：200-208.DOI：10.1111/j.1365-2753.2011.01800.x.
［6］肖惠敏，邝惠容.SF-12量表评价中国老年人生存质量的信度和效度分析［J］.中国老年学杂志，2014，34（4）：1018-1020.DOI：10.3969/j.issn.1005-9202.2014.04.073.
XIAO H M，KUANG H R.Reliability and validity analysis of SF-12 scale for evaluating the quality of life of Chinese elderly［J］.Chinese Journal of Gerontology，2014，34（4）：1018-1020.DOI：10.3969/j.issn.1005-9202.2014.04.073.
［7］杨士来，林雪玲，陈小菊，等.社区养老老年人生存质量及影响因素分析［J］.护理研究，2016，30（9）：1044-1047.DOI：10.3969/j.issn.1009-6493.2016.09.007.
YANG S L，LIN X L，CHEN X J，et al.Analysis of quality of life of elderly in community and its influencing factors［J］.Chinese Nursing Research，2016，30（9）：1044-1047.DOI：10.3969/j.issn.1009-6493.2016.09.007.
［8］李明晖，罗南.欧洲五维健康量表（EQ-5D）中文版应用介绍［J］.中国药物经济学，2009，4（1）：49-57.DOI：10.3969/j.issn.1673-5846.2009.01.007.
LI M H，LUO N.Introduction to the Chinese version of the Euroqol Group's 5-Domain Questionnaire［J］.China Journal of Pharmaceutical Economics，2009，4（1）：49-57.DOI：10.3969/j.issn.1673-5846.2009.01.007.
［9］FONG D Y，LAM C L，MAK K K，et al.The Short Form-12 Health Survey was a valid instrument in Chinese adolescents［J］.Journal of Clinical Epidemiology，2010，63（9）：1020-1029.DOI：10.1016/j.jclinepi.2009.11.011.
［10］LI L，WANG H M，SHEN Y.Chinese SF-36 Health Survey：translation，cultural adaptation，validation，and normalisation［J］.Journal of Epidemiology and Community Health，2003，57（4）：259.DOI：10.1136/jech.57.4.259.
［11］WARE J E J，SNOW K K，KOSINSKI M，et al.Applications of the SF-36.SF-36 health survey：manual and interpretation guide ［M］.Boston：The Health Institute，New England Medical Center，1993：1-11.
［12］丘金彩，许军，冯丽仪，等.SF-36应用于广东省公务员人群与健康相关的生存质量调查的信度和效度研究［J］.中国全科医学，2012，15（4）：386-389.DOI：10.3969/j.issn.1007-9572.2012.04.010.
QIU J C，XU J，FENG L Y，et al.Reliability and validity of
SF-36 in health-related quality of life survey among civil servants of Guangdong Province［J］.Chinese General Practice，2012，15（4）：386-389.DOI：10.3969/j.issn.1007-9572.2012.04.010.
［13］刘斐瑛.工作压力、职业倦怠与身心健康关系之研究：以台北市公立国中教师为例［D］.台北：台北护理健康大学，2014.
［14］王山，樊文洁，俞婉琦，等.SF-36量表应用于城市化居民生命质量评价的信度和效度分析［J］.中华流行病学杂志，2016，37（3）：344-347.DOI：10.3760/cma.j.issn.0254-6450.2016.03.010.
WANG S，FAN W J，YU W Q，et al.Analysis on reliability and validity of SF-36 scale in urban residents［J］.Chinese Journal of Epidemiology，2016，37（3）：344-347.DOI：10.3760/cma.j.issn.0254-6450.2016.03.010.
［19］APPEL L J，ANGELL S Y，COBB L K，et al.Population-wide sodium reduction：the bumpy road from evidence to
policy［J］.Ann Epidemiol，2012，22（6）：417-425.DOI：10.1016/j.annepidem.2012.04.003.
［20］MENTE A，O'DONNELL M，RANGARAJAN S，et al.Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension：a pooled analysis of data from four studies［J］.Lancet，2016，388（10043）：465-475.DOI：10.1016/S0140-6736(16)30467-6.
［21］GRAUDAL N A，HUBECK-GRAUDAL T，JüRGENS G.Effects of low-sodium diet vs.high-sodium diet on blood pressure，renin，aldosterone，catecholamines，cholesterol，and triglyceride（Cochrane Review）［J］.Am J Hypertens，2012，25（1）：1-15.
［22］HE F J，MACGREGOR G A.Salt reduction lowers cardiovascular risk：meta-analysis of outcome trials［J］.Lancet，2011，378（9789）：380-382.DOI：10.1016/S0140-6736（11）61174-4.
［23］GO A S，BAUMAN M A，KING S M C，et al.An effective approach to high blood pressure control：a science advisory from the American Heart Association，the American College of Cardiology，and the Centers for Disease Control and Prevention［J］.J Am Coll Cardiol，2014，63（12）：1230-1238.
［24］WILLIAMS B，POULTER N R，BROWN M J，et al.Guidelines for management of hypertension：report of the fourth working party of the British Hypertension Society，2004-BHSⅣ［J］.J Hum Hypertens，2004，18（3）：139-185.
［25］张新卫，肖媛媛，苏丹婷，等.浙江省城乡高血压患者知信行及干预需求分析［J］.健康教育与健康促进，2013，8（6）：429-432.DOI：10.16117/j.cnki.31-1974/r.2013.06.009.
ZHANG X W，XIAO Y Y，SU D T，et al.Analysis on the knowledge，attitude，practice and the intervention needs of hypertension patients in urban and rural areas of Zhejiang Province［J］.Health Education and Health Promotion，2013，8（6）：429-432.DOI：10.16117/j.cnki.31-1974/r.2013.06.009.
［26］周玉佳.重庆地区汉族人群与土家族人群膳食习惯与高血压患病的对比研究［D］.重庆：重庆医科大学，2016.
［27］中国高血压防治指南修订委员会.中国高血压防治指南（2010年修订版）［J］.中国实用乡村医生杂志，2012，19（10）：1-15.
Revision Committee of China's Guidelines for the Prevention and Treatment of Hypertension.Guidelines for prevention and treatment of hypertension in China（2010 revision）［J］.Chinese Practical Journal of Rural，2012，19（10）：1-15.

[1]	FENG Xiaoyu, LI Wanling, LYU Siman, NI Cuiping, WANG Haocheng, LIU Yu. International Research Status and Hot Spot Analysis of InterRAI HC Based on Bibliometrics [J]. Chinese General Practice, 2023, 26(34): 4351-4358.
[2]	GU Hanxin, LIU Yang, LIU Yuanli. Falls Prevention Intervention for Community-dwelling Older Adults from the Perspective of Policy Tools: an International Comparative Study [J]. Chinese General Practice, 2023, 26(34): 4231-4238.
[3]	WANG Yue, CHEN Qing, LIU Lurong. Detection Rate of Depression and Its Influencing Factors in Chinese Elderly: a Meta-analysis [J]. Chinese General Practice, 2023, 26(34): 4329-4335.
[4]	YU Xinyan, ZHAO Jun, ZHAO Xiaoye, JIANG Qingru, CHEN Yatian, WANG Yan, ZHANG Haicheng. Application of Mobile Smart Healthcare in the Prevention and Control of Cardiovascular Diseases in Elderly Patients with Chronic Diseases in Primary Care [J]. Chinese General Practice, 2023, 26(33): 4167-4172.
[5]	XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109.
[6]	ZHANG Shuai, LI Qin, LI Dongfeng, XIAO Jinping, LI Yunpeng. A Prospective Cohort Study of Solid Fuels Use and Risk of Hypertension in Chinese Older Adults [J]. Chinese General Practice, 2023, 26(32): 4001-4006.
[7]	JIAN Qiufeng, XU Ronghua, YAO Qian, ZHOU Yuanyuan. A Meta-analysis of the Prevalence and Influencing Factors of Post-stroke Cognitive Impairment in Chinese Elderly Patients [J]. Chinese General Practice, 2023, 26(32): 4070-4079.
[8]	GAO Jing, ZHOU Shangcheng, GAO Sande, ZOU Guanyang, CHEN Yingyao. Health-related Quality of Life and Its Influencing Factors in Patients with Prevention of Disease in Traditionnal Chinese Medicine based on EQ-5D-5L Scale [J]. Chinese General Practice, 2023, 26(32): 4043-4050.
[9]	CHEN Xi, ZHANG Juan, LI Lin, ZHANG Jiaqi, WU Yaoli, GUO Hui, WANG Chaoqun. Association between Physical Activity and Risk of All-cause Mortality in Middle-aged and Elderly People in China: a Prospective Cohort Study [J]. Chinese General Practice, 2023, 26(31): 3890-3895.
[10]	ZHANG Peng, GAO Ying, YANG Hongxi, WAN Chunxiao. Association between Serum Uric Acid Level and the Risk of Chronic Kidney Disease among the Elderly in Longevity Areas of China [J]. Chinese General Practice, 2023, 26(31): 3884-3889.
[11]	DUAN Yanqin, PENG Ying, LIU Shenglan, LIU Haijiao, YANG Huiqiong, HU Haiqing. Prevalence and Associated Factors of Potentially Inappropriate Medication among Elderly Outpatients [J]. Chinese General Practice, 2023, 26(31): 3902-3907.
[12]	ZHANG Ming, XU Jing, SUN Zhenhua, ZHAO Wenhao, MA Yingqian, ZHANG Jianqiao, SHEN Haiping. Improvement of Nutritional Status of Elderly Patients with Severe Obstruction Esophageal Carcinoma by Image-guided Photodynamic Therapy [J]. Chinese General Practice, 2023, 26(30): 3780-3784.
[13]	ZHOU Sijing, LUO Bangan, CAO Hui, ZHANG Xi, WANG Dongxin. Epidemiological Characteristics of Dementia and Its Correlation with Multimorbidity among Residents Aged 65 and Above [J]. Chinese General Practice, 2023, 26(29): 3616-3621.
[14]	WANG Xiaoran, ZHANG Dan. Influence of Multimorbidity on Anxiety Symptoms among Chinese Elderly People: a Propensity Score-matched Study [J]. Chinese General Practice, 2023, 26(29): 3622-3627.
[15]	ZHOU Xiaoqi, LIU Xinhui, ZHANG Wei, LI Changfeng, YAN Yaqiong. Association of Alanine Transaminase and Aspartate Aminotransferase/Alanine Transaminase Ratio with Type 2 Diabetes and Metabolic Syndrome in the Elderly [J]. Chinese General Practice, 2023, 26(29): 3645-3649.